Mochida Pharmaceutical gets grant for self-emulsifying preparation for enhanced EPA absorption
According to GlobalData’s company profile on Mochida Pharmaceutical, Cancer treatment biomarkers was a key innovation area identified from patents. Mochida Pharmaceutical's grant share as of February 2024 was 36%. Grant share is based on the ratio of …